Appetite suppressant compositions and methods thereof
AssigneeRed Mountain Holdings, LLC
InventorSuzanne Bentz
Life of this patent
Estimating the term…
Abstract
In various embodiments an appetite suppressant composition comprises at least one anorectic active ingredient (AAI); at least one of a nutritive substance, a controlled drug delivery agent (CDRA), and a cofactor; and optionally, an excipient. The AIA may comprise any one of phentermine, phendimetrazine, diethylpropion, naltrexone, and bupropion. The CDRA may comprise a cellulosic. The cofactor may comprise a chromium or selenium salt. In various embodiments, the compositions herein are provided in an oral capsule dosage form for GI-tract administration of the AAI. A method of suppressing appetite in individuals in need thereof are described.
Claims20
An appetite suppressant composition comprising:
- at least one anorectic active ingredient;
- at least one of a nutritive substance, a controlled drug delivery agent, and a cofactor;
- and optionally, an excipient.
A method of suppressing appetite in an individual, the method comprising orally administering to the individual in need thereof a therapeutically effective amount of an appetite suppressant composition comprising at least one anorectic active ingredient;
- at least one of a nutritive substance, a controlled drug delivery agent, and a cofactor;
- and optionally, an excipient, wherein the anorectic active ingredient is selected from the group consisting of phentermine, phendimetrazine, diethylpropion, naltrexone, bupropion, and mixtures thereof.
Dependencies are inferred from the claim text.